IOVANCE BIOTHERAPEUTICS INC revenue breakdown overview

IOVANCE BIOTHERAPEUTICS INC revenue for the last year amounted to 158.49 M EUR, the most of which — 158.49 M EUR — came from its highest performing source at the moment, Autologous Tumor Infiltrating Lymphocyte Cell Therapies, the year earlier bringing 1.08 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought IOVANCE BIOTHERAPEUTICS INC 155.56 M EUR, and the year before that — 1.08 M EUR.